Definitive (chemo)radiotherapy of enteric-type adenocarcinoma of the lung: time to unmask an underrated treatment option?

Fassi E, Mandruzzato M, Zamparini M, Bianchi S, Petrelli F, Baggi A, Alberti A, Grisanti S, Berruti A (2023) Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases. Cancer Treat Res 179:107176. https://doi.org/10.1016/j.lungcan.2023.107176

Article  Google Scholar 

Todisco A, Internò V, Stucci LS, Ostuni C, Lovero D, D’Oronzo S, Mele F, Duda L, Palmirotta R, Silvestris F (2019) Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma. Int J Biol Markers 34(4):421–426. https://doi.org/10.1177/1724600819877190

Article  CAS  PubMed  Google Scholar 

Wang Q, Zhang L, Li H, Liu L, Sun X, Liu H (2023) Clinical features and prognosis of pulmonary enteric adenocarcinoma: a retrospective study in China and the SEER database. Front Oncol 13:1099117. https://doi.org/10.3389/fonc.2023.1099117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teranishi S, Sugimoto C, Nagayama H, Segawa W, Miyasaka A, Hiro S, Maeda C, Tamura H, Masumoto N, Nagahara Y, Hirama N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T (2022) Combination of pembrolizumab with platinum-containing chemotherapy for pulmonary enteric adenocarcinoma. Cancer Diagn Progn 2(2):253–257. https://doi.org/10.21873/cdp.10102

Article  PubMed  PubMed Central  Google Scholar 

Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76(3 Suppl):S3–S9. https://doi.org/10.1016/j.ijrobp.2009.09.040

Article  PubMed  PubMed Central  Google Scholar 

Martorana E, Castorina P, Ferini G, Forte S, Mare M (2023) Forecasting individual patients’ best time for surgery in colon-rectal cancer by tumor regression during and after neoadjuvant radiochemotherapy. J Pers Med 13(5):851. https://doi.org/10.3390/jpm13050851

Article  PubMed  PubMed Central  Google Scholar 

Lin W, Li C, Clement EA, Brown CJ, Raval MJ, Karimuddin AA, Ghuman A, Phang PT (2024) Surgical outcomes in total neoadjuvant therapy for rectal cancer versus standard long-course chemoradiation: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 279(4):620–630. https://doi.org/10.1097/SLA.0000000000006161

Article  PubMed  Google Scholar 

Tu LF, Sheng LY, Zhou JY, Wang XF, Wang YH, Shen Q, Shen YH (2021) Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: report of six cases. World J Clin Cases 9(30):9236–9243. https://doi.org/10.12998/wjcc.v9.i30.9236

Article  PubMed  PubMed Central  Google Scholar 

Remon J, Soria JC, Peters S (2021) Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 32(12):1637–1642. https://doi.org/10.1016/j.annonc.2021.08.1994 (ESMO Guidelines Committee)

Article  CAS  PubMed  Google Scholar 

Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323(14):940–945. https://doi.org/10.1056/NEJM199010043231403

Article  CAS  PubMed  Google Scholar 

Marcenaro M, Vagge S, Belgioia L, Agnese D, Lamanna G, Mantero E, Gusinu M, Garelli S, Cavagnetto F, Agostinelli S, Corvò R (2013) Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor. Anticancer Res 33(2):655–660

PubMed  Google Scholar 

Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A (2018) Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 45(4):210–219. https://doi.org/10.1053/j.seminoncol.2018.06.002

Article  PubMed  Google Scholar 

Ferini G, Parisi S, Lillo S, Viola A, Minutoli F, Critelli P, Valenti V, Illari SI, Brogna A, Umana GE, Ferrantelli G, Giudice LG, Carrubba C, Zagardo V, Santacaterina A, Leotta S, Cacciola A, Pontoriero A, Pergolizzi S (2022) Impressive results after “metabolism-guided” lattice irradiation in patients submitted to palliative radiation therapy: preliminary results of LATTICE_01 multicenter study. Cancers 14(16):3909. https://doi.org/10.3390/cancers14163909

Article  PubMed  PubMed Central  Google Scholar 

Tubin S, Khan MK, Salerno G, Mourad WF, Yan W, Jeremic B (2019) Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor Hypoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiat Oncol 14(1):212. https://doi.org/10.1186/s13014-019-1410-1

Article  PubMed  PubMed Central  Google Scholar 

Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, Kalemkerian GP (2017) Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a phase 2 clinical trial. JAMA Oncol 3(10):1358–1365. https://doi.org/10.1001/jamaoncol.2017.0982

Article  PubMed  PubMed Central  Google Scholar 

Parisi S, Ferini G, Lillo S, Brogna A, Chillari F, Ferrantelli G, Settineri N, Santacaterina A, Platania A, Leotta S, Casablanca G, Russo A, Pontoriero A, Adamo V, Minutoli F, Bottari A, Cacciola A, Pergolizzi S (2023) Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study. Radiol Med 128(7):877–885. https://doi.org/10.1007/s11547-023-01659-w

Article  PubMed  Google Scholar 

Vadalà RE, Santacaterina A, Sindoni A, Platania A, Arcudi A, Ferini G, Mazzei MM, Marletta D, Rifatto C, Risoleti EV, Severo C, Pontoriero A, Iatì G, Pergolizzi S (2016) Stereotactic body radiotherapy in non-operable lung cancer patients. Clin Transl Oncol 18(11):1158–1159. https://doi.org/10.1007/s12094-016-1552-7

Article  PubMed  Google Scholar 

Puglisi C, Giuffrida R, Borzì G, Illari S, Caronia FP, Di Mattia P, Colarossi C, Ferini G, Martorana E, Sette G, Eramo A, Lorico A, Di Grazia A, Forte S (2022) Ex vivo irradiation of lung cancer stem cells identifies the lowest therapeutic dose needed for tumor growth arrest and mass reduction in vivo. Front Oncol 12:837400. https://doi.org/10.3389/fonc.2022.837400

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EdBook_AM.2014.34.e461

Article  PubMed  Google Scholar 

Nemoto Y, Kuroda K, Oyama R, Mori M, Shimajiri S, Tanaka F (2024) Case report: pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy. Front Oncol 14:1290757. https://doi.org/10.3389/fonc.2024.1290757

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif